Beyond Air, Inc.
inhaled nitric oxide delivery system for respiratory treatments
- Sector
- Medtech
- Headquarters
- GARDEN CITY, NY
- Founded
- 2015
- Latest Form D
- $20.6M, Oct 2024
- Total capital
- $77.5M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $77.5M
- 8 Form D · last Oct 2024
- 25 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 7
- 33 pending · first 2022
- Rank in peer group#255 of 1112
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 8th filing$20.6M
- Private capital raisedForm D · SEC · 7th filing$128K
- Private capital raisedForm D · SEC · 6th filing$1.4M
- Private capital raisedForm D · SEC · 5th filing$8M
- Private capital raisedForm D · SEC · 4th filing$9.8M
- Private capital raisedForm D · SEC · 3rd filing$663K
- Private capital raisedForm D · SEC · 2nd filing$37M
- Offering registeredForm D · SEC · 1st filing$10K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1112 peers
Line = medianMedtech · Device
- Granted patents#255 · top 23%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Amir Quinton AvnielExecutive Officer, DirectorNamed in SEC Form D filings
- Douglas Quinton LarsonExecutive OfficerNamed in SEC Form D filings
- Erick P. LuceraDirectorNamed in SEC Form D filings
- Jeff Lynn MyersExecutive OfficerNamed in SEC Form D filings
- Michael A. GaulExecutive OfficerNamed in SEC Form D filings
- Robert Lynn CareyDirectorNamed in SEC Form D filings
Show all 10 people
- Ron A. BentsurDirectorNamed in SEC Form D filings
- Steven A. LisiExecutive Officer, DirectorNamed in SEC Form D filings
- William P. ForbesDirectorNamed in SEC Form D filings
- Yoori P LeeDirectorNamed in SEC Form D filings
What it has protected
USPTO · 7 granted of 40- GrantedMethods Employing Gaseous Nitric Oxide For Inhibiting Tumor GrowthUSPTOUS 12,691,234
- GrantedSystem and Method for Delivery of Gas to a TissueUSPTOUS 12,636,445
- PendingMethods And Apparatuses For Delivering Gaseous Nitric Oxide TreatmentsUSPTOApplication 19053541
Show all 40 patent records
- Methods Employing Gaseous Nitric Oxide For Inhibiting Tumor GrowthJul 28, 2026 · US 12,691,234Granted
- System and Method for Delivery of Gas to a TissueMay 26, 2026 · US 12,636,445Granted
- Methods And Apparatuses For Delivering Gaseous Nitric Oxide TreatmentsJan 8, 2026 · Application 19053541Pending
- Cancer Treatment Using Ultra-high Concentration Gaseous Nitric Oxide And A Checkpoint InhibitorNov 6, 2025 · Application 18987013Pending
- Nitric Oxide Generation SystemOct 7, 2025 · US D1,097,117Granted
- Display Screen or Portion Thereof with Graphical User InterfaceJul 22, 2025 · US D1,085,129Granted
- Methods Of Producing Tumor Vaccines And Uses ThereofJul 18, 2024 · Application 18563241Pending
- System And Method For Delivery Of Gas To A TissueNov 21, 2023 · US 11,819,606Granted
- Filter CartridgeOct 31, 2023 · US D1,003,416Granted
- Inhalation Of Nitric OxideDec 15, 2022 · Application 17587170Pending
- System And Method For Delivery Of Gas To A TissueDec 13, 2022 · US 11,524,127Granted
- Inhalation Of Nitric OxideJan 27, 2022 · Application 17391284Pending
- Inhalation Of Nitric OxideOct 15, 2020 · Application 16863929Pending
- Inhalation Of Nitric OxideSep 10, 2020 · Application 16863935Pending
- Methods Of Selecting Treatment For CancerApplication PCTUS2023014715Pending
- Cancer Treatment Using Gaseous Nitric Oxide And PembrolizumabApplication 63439435Pending
- Methods And Apparatuses For Delivering Gaseous Nitric Oxide TreatmentsApplication 63399183Pending
- Cancer Treatment Using Gaseous Nitric Oxide, Immune Checkpoint Modulators And Immune AdjuvantsApplication 63358542Pending
- Gaseous Nitric Oxide As A Sensitizing Treatment To Immune Checkpoint ModulatorsApplication 63358547Pending
- Cancer Treatment Using Gaseous Nitric Oxide And PembrolizumabApplication 63358540Pending
- Methods Of Selecting Treatment For CancerApplication 63317133Pending
- Methods And Apparatuses For Treating Tumors Using Gaseous Nitric OxideApplication 63090345Pending
- Methods and Apparatuses for Treating Lung Metastases and Tumors with Gaseous Nitric Oxide InhalationsApplication 63071573Pending
- Methods And Apparatuses For Treating Tumors Using Gaseous Nitric OxideApplication 63027120Pending
- Methods And Apparatuses For Treating Tumors Using Gaseous Nitric OxideApplication 62985611Pending
- Apparatus And Method Of Using Same For Treating Tumors Using Gaseous Nitric OxideApplication 62984926Pending
- Methods And Apparatuses For Treating Tumors Using Gaseous Nitric OxideApplication 62982817Pending
- Methods And Apparatuses For Treating Tumors Using Gaseous Nitric OxideApplication 62963849Pending
- Methods And Apparatuses For Treating Tumors Using Gaseous Nitric OxideApplication 62939975Pending
- Inhalation Of Nitric OxideApplication PCTUS2018058956Pending
- Inhalation Of Nitric OxideApplication PCTUS2018058962Pending
- Systems And Methods For Delivery Of Nitric Oxide GasApplication PCTUS2025055858Pending
- Systems And Methods For Delivery Of Nitric Oxide GasApplication 19584000Pending
- Cancer Treatment Using A Low Volumetric Flow Rate Of Ultra-high Concentration Gaseous Nitric OxideApplication PCTUS2025023017Pending
- Systems and Methods for Delivery of Nitric Oxide GasApplication 63722537Pending
- Cancer Treatment Using A Low Flow Of Ultra-high Concentration Gaseous Nitric OxideApplication 63716164Pending
- Systems And Methods For Delivery Of Nitric Oxide GasApplication PCTUS2024054110Pending
- System And Method For Delivery Of Gas To A TissueApplication PCTUS2024029884Pending
- Cancer Treatment Using A Low Flow Of Ultra-high Concentration Gaseous Nitric OxideApplication 63573933Pending
- Gas Sample Line MaintenanceApplication 63596002Pending
Related companies, and why
- RESPIRA THERAPEUTICS, INC.Similar federal contract value in Medtech · null in contracts
- RESTOR3D, Inc.Similar federal contract value in Medtech · null in contracts
- WIDETRONIX INC.Similar federal contract value in Medtech · null in contracts
- Wincs International, LLCSimilar federal contract value in Medtech · null in contracts
- Sense Diagnostics, LLCSimilar federal contract value in Medtech · null in contracts
- CVERGENX, INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .